The risk of overdiagnosis of antiphospholipid antibody syndrome

Thrombosis and Haemostasis

Volumn 86, Issue 3, 2001, Pages 933-

  Pengo, V ^a   Biasiolo, A ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA2 GLYCOPROTEIN 1; BINDING PROTEIN; CARDIOLIPIN ANTIBODY; COMPLEMENT COMPONENT C4; COMPLEMENT FACTOR H; GLYCOPROTEIN GP 120; KALLIKREIN; LUPUS ANTICOAGULANT;

ANTIBODY TITER; ANTIPHOSPHOLIPID SYNDROME; BLOOD ANALYSIS; CLINICAL PROTOCOL; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LABORATORY DIAGNOSIS; LABORATORY TEST; LETTER; PATIENT CODING; PLASMA; PRIORITY JOURNAL; STANDARD; THROMBOEMBOLISM;

EID: 0034852546     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1616156     Document Type: Letter

References (4)

1. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome
2. 2-Glycoprotein-I is bound to a suitable surface
3. Autoantibodies to phospholipid binding plasma proteins in patients with thrombosis and phospholipid-reactive antibodies
4. Some patients with antiphospholipid syndrome express hitherto undescribed antibodies to cardiolipin-binding proteins